EGFR, epidermal growth factor receptor, 1956

N. diseases: 124; N. variants: 58
Source: CURATED ×
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0205644
Disease: Carcinoma, Granular Cell
Carcinoma, Granular Cell
0.300 Biomarker disease CTD_human Identification of gene expression profiling associated with erlotinib-related skin toxicity in pancreatic adenocarcinoma patients. 27720938 2016
CUI: C0205644
Disease: Carcinoma, Granular Cell
Carcinoma, Granular Cell
0.300 Biomarker disease CTD_human Intermittent chemotherapy and erlotinib for nonsmokers or light smokers with advanced adenocarcinoma of the lung: a phase II clinical trial. 21541241 2011
CUI: C0205644
Disease: Carcinoma, Granular Cell
Carcinoma, Granular Cell
0.300 Biomarker disease CTD_human MET amplification identifies a small and aggressive subgroup of esophagogastric adenocarcinoma with evidence of responsiveness to crizotinib. 22042947 2011
CUI: C0205644
Disease: Carcinoma, Granular Cell
Carcinoma, Granular Cell
0.300 Biomarker disease CTD_human Co-activation of epidermal growth factor receptor and c-MET defines a distinct subset of lung adenocarcinomas. 20934974 2010
CUI: C0205644
Disease: Carcinoma, Granular Cell
Carcinoma, Granular Cell
0.300 Biomarker disease CTD_human Mammary adenocarcinomas induced by medroxyprogesterone acetate: hormone dependence and EGF receptors of BALB/c in vivo sublines. 2523869 1989